Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Megan Levings, Professor of Surgery and Biomedical Engineering, University of British Columbia

Why Canada’s next big infrastructure investment should be in biomanufacturing

While Canada invests billions in infrastructure projects and national defence, a critical area of investment remains overlooked: biomanufacturing.

Biomanufacturing is the production of biological products like vaccines and cell therapies at the scale and quality needed for human use. It encompasses everything needed to reliably produce and deliver safe, effective biological products from development to commercial-scale production.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.